Expression of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apolipoprotein E2/2 phenotype
- 4 August 1991
- journal article
- Published by Wiley in Journal of Internal Medicine
- Vol. 230 (2) , 183-186
- https://doi.org/10.1111/j.1365-2796.1991.tb00428.x
Abstract
Post‐surgical hypothyroidism developed in a now 43‐year‐old woman with complete insufficiency of the anterior pituitary gland who discontinued levothyroxine replacement therapy. Serum cholesterol and serum triglyceride levels increased in parallel, and classical type III hyperlipoproteinaemia (HLP) with xanthoma striata palmaris developed. The patient is homozygous for apolipoprotein (apo) E2. The case reported here represents the first example of manifestation of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apo E2/2 phenotype.Keywords
This publication has 18 references indexed in Scilit:
- Apolipoprotein E polymorphism in health and diseasePublished by Elsevier ,2004
- Effect of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitusAtherosclerosis, 1990
- Expression of type III hyperlipoproteinemia in an adolescent patient with hypothyroidismThe Journal of Pediatrics, 1988
- Apolipoprotein E polymorphism and atherosclerosis.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Polymorphism of apolipoprotein EClinical Genetics, 1979
- Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in manNature, 1977
- Pediatric familial type III hyperlipoproteinemiaMetabolism, 1976
- A longitudinal assessment of lipid ratios in the diagnosis of type III hyperlipoproteinaemiaClinica Chimica Acta; International Journal of Clinical Chemistry, 1975
- Aggravation of broad- disease (type 3 hyperlipoproteinemia) by hypothyroidismArchives of internal medicine (1960), 1972
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955